Healthcare & Life Sciences
Glycomimetics
United States
series-b
series-b
Stage
1
Investors
About
Glycomimetics is a clinical-stage biotechnology company developing novel therapies targeting glycomimetic molecules to treat diseases such as cancer and sickle cell disease.
Explore Glycomimetics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.